Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Franklin Resources, Inc. (BEN) Price & Performance

Franklin Resources, Inc.Trade

Price performance (Past 24H)

Key statistics

Alcon AG vs Franklin Resources, Inc. — how do they compare? Alcon AG trades at $72.39 (market cap $36.44B), while Franklin Resources, Inc. trades at $33.37 (market cap $16.95B). The key difference: Alcon AG is far larger — about 2.1× Franklin Resources, Inc.'s market cap, and Franklin Resources, Inc. pays the higher dividend (3.96%). Which is the better fit depends on your goals.

ALCBEN
Market Cap
$36.44B$16.95B
Sector
HealthFinancials
52-Week High
$90.12$35.77
52-Week Low
$62.02$21.18
Enterprise Value
$40.28B$29.90B
Dividend Yield
0.48%3.96%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alcon AG

No Aura AI signal available yet.

Franklin Resources, Inc.

Franklin Resources (BEN) trades at $33.52, down 0.74% on the day, with a bullish technical signal supported by moving averages. The company reported Q2 2026 EPS of $0.72, beating estimates, and achieved record AUM of $1.80 trillion as of July 31, 2026, driven by strong inflows and diversification efforts. Valuation ratios include a P/E of 22.69 and P/S of 1.85, while profitability metrics show a net income margin of 8.72%.

The outlook is positive with earnings beats and AUM growth, but risks include weaker ROE of 1.34% and net cash outflows. Analyst consensus price target is $36.50, suggesting potential upside, supported by a 'Buy' rating from 22% of analysts. Investors should monitor margin expansion and competitive pressures in the asset management sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Franklin Resources, Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.

Read more on BEN